Onconetix (ONCO) vs Revelation Biosciences (REVB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Onconetix is the larger company by market cap ($3.4 million vs $3.0 million), about 1.1 times the size. On valuation, Onconetix trades at a lower trailing P/E (0.0x vs 0.2x for Revelation Biosciences).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ONCO | REVB |
|---|---|---|
| Share price | $0.6414 | $0.7513 |
| Market cap | $3.36M | $2.99M |
| 1-day change | -1.97% | -3.68% |
| P/E ratio (TTM) | 0.00 | 0.16 |
| EPS (TTM) | $310.39 | $4.60 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $207.00 | $5.96 |
| 52-week low | $0.58 | $0.75 |
| Distance from 52-week high | -99.69% | -87.39% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +2262.57% |
| Average volume | 2.96M | 39.50K |
| Shares outstanding | 5.24M | 3.98M |
| Employees | 2 | 8 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Revelation Biosciences trades at a higher earnings multiple (0.2x vs 0.0x trailing P/E).
About Onconetix
ONCO stock →Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
About Revelation Biosciences
REVB stock →Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health.
Health Care · Biotechnology: Pharmaceutical Preparations · 8 employees
ONCO vs REVB FAQ
Which is bigger, Onconetix or Revelation Biosciences?
Onconetix (ONCO) is larger, with a market capitalization of $3.36M compared with $2.99M for Revelation Biosciences (REVB).
Which has the lower P/E ratio, ONCO or REVB?
ONCO has the lower trailing P/E at 0.0, versus 0.2 for REVB. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Onconetix and Revelation Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.